The pooled results indicated that increasing CD25 expression was significantly correlated with inferior outcomes for AML, the unfavorable impact was still significant in subgroup analyses across ethnicity, age group, AML subtype, cut-off value, statistical methodologies and detection method, indicating that CD25 expression is an independent prognostic factor for patients with AML. Here, IL2RA is linked to acute myeloid leukemia.